Personalized Antinausea Regimens More Effective in Cancer Patients Receiving Emetogenic ChemotherapyNovember 23, 2015
A personalized approach to treating nausea and vomiting, the most expected side effects of chemotherapy, is far more effective than the existing one-size-fits-all guidelines.
TESARO Inc has announced that rolapitant (Varubi), a neurokinin-1 (NK-1) receptor antagonist, is now available in the United States.
Study findings may explain why chemotherapy drugs such as gemcitabine are not effective for many patients with pancreatic cancer, and perhaps point to new approaches to treatment including enhancing gemcitabine's ability to stop tumor growth.
The protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in patients with breast cancer, also marks ovarian cancers likely to be resistant to the common chemotherapy cisplatin.
Gene Expression Test Can Lead to More Effective Treatment Decisions In Patients With Invasive Lobular Carcinoma (ILC) Breast CancerNovember 06, 2015
Most patients with invasive lobular carcinoma (ILC) breast cancer could be treated with hormones alone and not with chemotherapy.
Ramosetron plus dexamethasone and aprepitant is as effective and tolerable as ondansetron.
An analysis of an international, cooperative-led trial of patients with locally advanced NSCLC has shown that those who received IMRT had less severe lung toxicity and were able to better tolerate their chemotherapy, compared with patients who received 3-D CRT.
High-Dose Chemo and Stem Cell Transplantation Results in Long-Term Survival for Patients With AmyloidosisOctober 27, 2015
Patients with light-chain amyloidosis who are treated with high-dose chemotherapy and autologous stem cell transplantation have the greatest success for long-term survival.
Surviving neuroblastoma as a child can come with just as many challenges as the cancer itself. But a team of surgeons is in the nascent stages of developing a more targeted method for delivering chemotherapy, with lower toxicity.
Remarkable early results were reported from a phase 1 trial of a novel agent, rovalpituzumab tesirine (Rova-T, or S16LD6.5), in 79 patients with SCLC who had progressed after first- or second-line therapy.
Young women undergoing chemotherapy for breast cancer may be more likely to remain fertile if they also receive hormonal treatment, according to new research presented at ECC2015.
How can accidental exposure/leaks when handling chemotherapy drugs that incompatible with the closed system device (CSD) be prevented?
A patient's microbial diversity, even before they start cancer treatment, can be linked to risk of infection during induction chemotherapy.
Imaging Method Has Potential to Predict Effectiveness of Induction Chemotherapy in Patients With Head and Neck CancerOctober 01, 2015
Researchers identified a potential new way to predict which patients with head and neck cancer will benefit most from chemotherapy.
What is the correct sequence for infusing FOLFIRINOX?
Use of chemotherapy is inverse to disease risk in patients with breast cancer when genetic assay is usedSeptember 23, 2015
Use of the 21-gene recurrence test score was associated with lower chemotherapy use in high-risk patients and greater use of chemotherapy in low-risk patients compared with not using the test score among a large group of Medicare beneficiaries, according to a recent investigation.
Blocking the PHD1 oxygen sensor hinders the activation of p53, which aids CRC cells in resisting chemotherapy, a major clinical issue in the treatment of CRC. These findings indicate that PHD1 inhibition may have valuable therapeutic potential.
Early discharge after intensive acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) can reduce both costs and use of intravenous antibiotics, according to a new study.
Adjuvant chemotherapy does not improve QOL, recurrence, and survival in patients with stage II colon cancerSeptember 10, 2015
Compliance with safety protocols can minimize risks from occupational exposure to antineoplastic drugs. Are you doing all you can do?
Chemotherapy prolongs life for older adults with most types of cancer, but for women older than 80 years with breast cancer, the chances of improved survival due to chemotherapy are significantly lower, according to a recent study.
Shutting down the healing action of certain white blood cells triggered by chemotherapy may help prevent the spread of cancer.
A combination therapy increased survival rates for individuals with newly diagnosed metastatic, hormone-sensitive prostate cancer.
The first study to examine the effects of combined radiation and chemotherapy on the healthy brain tissue of glioblastoma patients has revealed specific structural brain changes.
Safest timing of pegfilgrastim administration based on white blood cell (WBC) count seems to be 72 hours following chemotherapy.
Subcutaneous power ports seem to rarely function properly when administering irinotecan but function properly when the regimen changes. Is there an explanation for why this happens?
Is there a standard process for administering KCL through an IV?
This literature review sought to analyze the quality of evidence that supports management practices of cytotoxic drug extravasation.
Chemotherapy does not improve survival for older women with breast cancer.
Activated neutrophils may trigger potentially fatal hemorrhage associated with some cancer treatmentsAugust 10, 2015
Blocking the passage of immune cells could prevent dangerous complications in patients undergoing transplants or chemotherapy.
- Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme
- Blood Test Indicates Breast Cancer Tumors Developed Resistance to Hormone Treatment
- Breakthrough Advance Announced in International Blood Cancer Drug Trial
- Yoga Provides Mental, Emotional, and Physical Benefits for Patients With Cancer
- Citywide Program Increases Rates, Eliminates Racial Disparities in Colorectal Cancer Screening
- Breastfeeding Associated With A Reduced Risk of Aggressive Breast Cancer
- Hospitals Should Enact Bereavement Programs, Researchers Urge
- Physical Activity Communications Should be Part of Oncology Care Clinic Visits With Patients
- Communication Practices of Many US Physicians May Be Discouraging HPV Vaccination
- Chemo, Tamoxifen May Increase VTE Risk Among Patients With Breast Cancer
- New Blood Test Improves Screening for Prostate Cancer
- Concurrent Chemoradiotherapy Using Paclitaxel Plus Cisplatin in the Treatment of Elderly Patients With Esophageal Cancer
- International Study Charts Genetic Trajectory for Melanoma
- Risk of Several Autoimmune Diseases Increased in Childhood Cancer Survivors
- Protein Biomarker Assays for Diagnosing Thyroid Cancer May Show Inaccurate Readings
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|